| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.5 | 7e-24 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.38 | 6e-15 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-12 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-10 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.53 | 1e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0003 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0005 |